432 related articles for article (PubMed ID: 36902045)
1. Radiogenomics in Renal Cancer Management-Current Evidence and Future Prospects.
Ferro M; Musi G; Marchioni M; Maggi M; Veccia A; Del Giudice F; Barone B; Crocetto F; Lasorsa F; Antonelli A; Schips L; Autorino R; Busetto GM; Terracciano D; Lucarelli G; Tataru OS
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902045
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of benign from malignant solid renal lesions with MRI-based radiomics and machine learning.
Massa'a RN; Stoeckl EM; Lubner MG; Smith D; Mao L; Shapiro DD; Abel EJ; Wentland AL
Abdom Radiol (NY); 2022 Aug; 47(8):2896-2904. PubMed ID: 35723716
[TBL] [Abstract][Full Text] [Related]
3. Deep learning and radiomics: the utility of Google TensorFlow™ Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT.
Coy H; Hsieh K; Wu W; Nagarajan MB; Young JR; Douek ML; Brown MS; Scalzo F; Raman SS
Abdom Radiol (NY); 2019 Jun; 44(6):2009-2020. PubMed ID: 30778739
[TBL] [Abstract][Full Text] [Related]
4. Prostate Cancer Radiogenomics-From Imaging to Molecular Characterization.
Ferro M; de Cobelli O; Vartolomei MD; Lucarelli G; Crocetto F; Barone B; Sciarra A; Del Giudice F; Muto M; Maggi M; Carrieri G; Busetto GM; Falagario U; Terracciano D; Cormio L; Musi G; Tataru OS
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576134
[TBL] [Abstract][Full Text] [Related]
5. Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma.
Zeng H; Chen L; Wang M; Luo Y; Huang Y; Ma X
Aging (Albany NY); 2021 Mar; 13(7):9960-9975. PubMed ID: 33795526
[TBL] [Abstract][Full Text] [Related]
6. Radiogenomics in prostate cancer evaluation.
Thenault R; Gasmi A; Khene ZE; Bensalah K; Mathieu R
Curr Opin Urol; 2021 Jul; 31(4):424-429. PubMed ID: 34009176
[TBL] [Abstract][Full Text] [Related]
7. Discriminating malignant and benign clinical T1 renal masses on computed tomography: A pragmatic radiomics and machine learning approach.
Uhlig J; Biggemann L; Nietert MM; Beißbarth T; Lotz J; Kim HS; Trojan L; Uhlig A
Medicine (Baltimore); 2020 Apr; 99(16):e19725. PubMed ID: 32311963
[TBL] [Abstract][Full Text] [Related]
8. Radiomics and Artificial Intelligence for Renal Mass Characterization.
Lubner MG
Radiol Clin North Am; 2020 Sep; 58(5):995-1008. PubMed ID: 32792129
[TBL] [Abstract][Full Text] [Related]
9. Radiogenomics and Artificial Intelligence Approaches Applied to Cardiac Computed Tomography Angiography and Cardiac Magnetic Resonance for Precision Medicine in Coronary Heart Disease: A Systematic Review.
Infante T; Cavaliere C; Punzo B; Grimaldi V; Salvatore M; Napoli C
Circ Cardiovasc Imaging; 2021 Dec; 14(12):1133-1146. PubMed ID: 34915726
[TBL] [Abstract][Full Text] [Related]
10. A Radiomic-based Machine Learning Algorithm to Reliably Differentiate Benign Renal Masses from Renal Cell Carcinoma.
Nassiri N; Maas M; Cacciamani G; Varghese B; Hwang D; Lei X; Aron M; Desai M; Oberai AA; Cen SY; Gill IS; Duddalwar VA
Eur Urol Focus; 2022 Jul; 8(4):988-994. PubMed ID: 34538748
[TBL] [Abstract][Full Text] [Related]
11. Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature.
Campi R; Stewart GD; Staehler M; Dabestani S; Kuczyk MA; Shuch BM; Finelli A; Bex A; Ljungberg B; Capitanio U
Eur Urol Oncol; 2021 Feb; 4(1):22-41. PubMed ID: 33408053
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Benign and Malignant Solid Renal Masses: Machine Learning-Based CT Texture Analysis.
Erdim C; Yardimci AH; Bektas CT; Kocak B; Koca SB; Demir H; Kilickesmez O
Acad Radiol; 2020 Oct; 27(10):1422-1429. PubMed ID: 32014404
[TBL] [Abstract][Full Text] [Related]
13. Radiomics in stratification of pancreatic cystic lesions: Machine learning in action.
Dalal V; Carmicheal J; Dhaliwal A; Jain M; Kaur S; Batra SK
Cancer Lett; 2020 Jan; 469():228-237. PubMed ID: 31629933
[TBL] [Abstract][Full Text] [Related]
14. Radiomics and Artificial Intelligence: Renal Cell Carcinoma.
Raman AG; Fisher D; Yap F; Oberai A; Duddalwar VA
Urol Clin North Am; 2024 Feb; 51(1):35-45. PubMed ID: 37945101
[TBL] [Abstract][Full Text] [Related]
15. Shape and texture-based radiomics signature on CT effectively discriminates benign from malignant renal masses.
Yap FY; Varghese BA; Cen SY; Hwang DH; Lei X; Desai B; Lau C; Yang LL; Fullenkamp AJ; Hajian S; Rivas M; Gupta MN; Quinn BD; Aron M; Desai MM; Aron M; Oberai AA; Gill IS; Duddalwar VA
Eur Radiol; 2021 Feb; 31(2):1011-1021. PubMed ID: 32803417
[TBL] [Abstract][Full Text] [Related]
16. Machine learning-based unenhanced CT texture analysis for predicting BAP1 mutation status of clear cell renal cell carcinomas.
Kocak B; Durmaz ES; Kaya OK; Kilickesmez O
Acta Radiol; 2020 Jun; 61(6):856-864. PubMed ID: 31635476
[TBL] [Abstract][Full Text] [Related]
17. Novel imaging techniques of rectal cancer: what do radiomics and radiogenomics have to offer? A literature review.
Horvat N; Bates DDB; Petkovska I
Abdom Radiol (NY); 2019 Nov; 44(11):3764-3774. PubMed ID: 31055615
[TBL] [Abstract][Full Text] [Related]
18. Improved characterization of sub-centimeter enhancing breast masses on MRI with radiomics and machine learning in BRCA mutation carriers.
Lo Gullo R; Daimiel I; Rossi Saccarelli C; Bitencourt A; Gibbs P; Fox MJ; Thakur SB; Martinez DF; Jochelson MS; Morris EA; Pinker K
Eur Radiol; 2020 Dec; 30(12):6721-6731. PubMed ID: 32594207
[TBL] [Abstract][Full Text] [Related]
19. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.
Gao J; Ye F; Han F; Jiang H; Zhang J
Front Immunol; 2022; 13():956679. PubMed ID: 36177018
[TBL] [Abstract][Full Text] [Related]
20. Radiogenomics in renal cell carcinoma.
Alessandrino F; Shinagare AB; Bossé D; Choueiri TK; Krajewski KM
Abdom Radiol (NY); 2019 Jun; 44(6):1990-1998. PubMed ID: 29713740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
